Avecho Biotechnology Ltd Capital Reinvestment Ratio

Latest as of December 2019: 0.00x

Avecho Biotechnology Ltd capital reinvestment ratio. Avecho Biotechnology Ltd (AVE) has a Capital Reinvestment Ratio of 0.00x as of December 2019, meaning it reinvests 0% of its operating cash flow (AU$1.19 Million) in capital expenditures (AU$5.15K). Check Avecho Biotechnology Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$1.19 Million

AUD

Capital Expenditures

AU$5.15K

AUD

Data as of

Dec 2019

Most recent filing

Capital Reinvestment Ratio of Avecho Biotechnology Ltd (2019–2019)

Capital reinvestment ratio of Avecho Biotechnology Ltd from 2019 to 2019. This chart tracks Avecho Biotechnology Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Avecho Biotechnology Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Avecho Biotechnology Ltd Capital Reinvestment Ratio by Year (2019–2019)

Avecho Biotechnology Ltd capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see AVE operating cash flow.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2019	0.00x	AU$1.19 Million	AU$5.15K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow